Study of GSK1363089 in Metastatic Gastric Cancer
NCT00725712
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Gastrointestinal Tract
Interventions
DRUG:
GSK1363089 (formerly XL880)
Sponsor
GlaxoSmithKline